The role of tumor hypoxia in MUC1-positive breast carcinomas

Virchows Archiv

Volumn 459, Issue 4, 2011, Pages 367-375

  Zanetti, Juliana Silva ^a   Soave, Danilo Fiqueredo ^a   Oliveira Costa, João Paulo ^a   Da Silveira, Giórgia Gobbi ^a   Ramalho, Leandra Náira Zambelli ^a   Garcia, Sérgio Britto ^a   Zucoloto, Sérgio ^a   Ribeiro Silva, Alfredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; HIF 1 ; Hypoxia; MUC1; NF B; Tissue microarray

Indexed keywords

CARBONATE DEHYDRATASE IX; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 1; PROGESTERONE RECEPTOR; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL HYPOXIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUCIN-1; NEOPLASM STAGING; NF-KAPPA B; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80855123672     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1142-6     Document Type: Article

References (41)

1. A Ribeiro-Silva MA Moutinho HB Moura, et al. 2006 Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival Histol Histopathol 21 373 382 16437383 1:CAS:528:DC%2BD28Xls1Srsrw%3D
2. M Koda L Kanczuga-Koda M Sulkowska, et al. 2010 Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy BMC Cancer 10 1 8 10.1186/1471-2407-10-320
3. L Sun S Lin R Zhao, et al. 2010 The saponin monomer of dwarf lilyturf tuber, DT-13, reduces human breast cancer cell adhesion and migration during hypoxia via regulation of tissue factor Biol Pharm Bull 33 1192 1198 20606312 10.1248/bpb.33.1192 1:CAS:528:DC%2BC3cXhtFert7vJ
4. D Vordermark 2010 Hypoxia-specific targets in cancer therapy: role of splice variants BMC Med 12 1 3
5. CL Chen JS Chu WC Su 2010 Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX Virchows Arch 457 53 61 20526721 10.1007/s00428-010-0938-0 1:CAS:528:DC%2BC3cXotlyqt70%3D
6. A Giatromanolaki MI Koukourakis E Sivridis, et al. 2001 Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer Cancer Res 61 7992 7998 11691824 1:CAS:528:DC%2BD3MXotlars7s%3D (Pubitemid 33049392)
7. U Schumacher E Adam 1998 Immunohistochemical detection of the MUC1 gene product in human cancers grown in scid mice J Histochem Cytochem 46 127 134 9405502 10.1177/002215549804600116 1:CAS:528:DyaK1cXlsVGi (Pubitemid 28030518)
8. EA Rakha WG Boyce DA El-Rehim, et al. 2005 Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer Mod Pathol 18 1295 1304 15976813 10.1038/modpathol.3800445 1:CAS:528:DC%2BD2MXhtVWiu7fN (Pubitemid 41348648)
9. JT O'Connell S Zhi-Ming D Ehud, et al. 1998 Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis Hum Pathol 29 1517 1523 9865841 10.1016/S0046-8177(98)90024-7 (Pubitemid 28563988)
10. D Raina R Ahmad MD Joshi, et al. 2009 Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells Cancer Res 69 5133 5141 19491255 10.1158/0008-5472.CAN-09-0854 1:CAS:528:DC%2BD1MXnt1equrg%3D
11. JA Voynow SJ Gendler MC Rose 2006 Regulation of mucin genes in chronic inflammatory airway diseases Am J Respir Cell Mol Biol 34 661 665 16456183 10.1165/rcmb.2006-0035SF 1:CAS:528:DC%2BD28Xms12lsbc%3D (Pubitemid 43825329)
12. H Nassar V Pansare H Zhang, et al. 2004 Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein Mod Pathol 17 1045 1050 15154007 10.1038/modpathol.3800166 1:CAS:528:DC%2BD2cXnslOjtLw%3D (Pubitemid 39128230)
13. MC Abba MI Nunez AG Colussi, et al. 2006 GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells Breast Cancer Res 8 R64 17078870 10.1186/bcr1617 (Pubitemid 44911886)
14. C Heuser M Ganser A Hombach, et al. 2003 An anti-MUC1-antibody- interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells Br J Cancer 89 1130 1139 12966437 10.1038/sj.bjc.6601267 1:CAS:528:DC%2BD3sXntVKnsrk%3D (Pubitemid 37243025)
15. CL Hattrup SJ Gendler 2006 MUC1 alters oncogenic events and transcription in human breast cancer cells Breast Cancer Res 8 R37 16846534 10.1186/bcr1515 (Pubitemid 44057562)
16. NN Khodarev SP Pitroda MA Beckett, et al. 2009 MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer Cancer Res 69 2833 2837 19318547 10.1158/0008-5472.CAN-08-4513 1:CAS:528:DC%2BD1MXjvVWis74%3D
17. MJ Brayman N Dharmaraj E Lagow, et al. 2007 MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y Mol Endocrinol 21 2725 2737 17717071 10.1210/me.2006-0539 1:CAS:528:DC%2BD2sXht1ynsrfO (Pubitemid 350035154)
18. ST Huyn JB Burton M Sato, et al. 2009 A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis Clin Cancer Res 15 3126 3134 19366829 10.1158/1078-0432.CCR-08-2666 1:CAS:528:DC%2BD1MXltFOrtbg%3D
19. L Yin Y Li J Ren, et al. 2003 Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress J Biol Chem 278 35458 3564 12826677 10.1074/jbc.M301987200 1:CAS:528: DC%2BD3sXntVajsr0%3D (Pubitemid 37102316)
20. V Apostolopoulos IF Mckenzie GA Pietersz 1996 Breast cancer immunotherapy: current status and future prospects Immunol Cell Biol 74 457 464 8912009 10.1038/icb.1996.76 1:CAS:528:DyaK28XmvFKmsbs%3D (Pubitemid 26342131)
21. PL Fitzgibbons DL Page D Weaver, et al. 2000 Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 966 978 10888772 1:STN:280:DC%2BD3czptVKrtQ%3D%3D
22. A Mangia A Chiriatti S Tommasi, et al. 2009 BRCA1 expression and molecular alterations in familial breast cancer Histol Histopathol 24 69 76 19012246 1:STN:280:DC%2BD1cjksVCjtw%3D%3D
23. L Rydén K Jirstro M Haglund, et al. 2010 Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up Breast Cancer Res Treat 120 491 498 20135347 10.1007/s10549-010-0758-6
24. AR Sangoi JP Higgins RV Rouse, et al. 2009 Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact Mod Pathol 22 660 667 19270645 10.1038/modpathol.2009.16 1:CAS:528: DC%2BD1MXlt1SltLc%3D
25. SE Singletary FL Greene 2003 Revision of breast cancer staging: the 6th edition of the TNM classification Semin Surg Oncol 21 53 59 12923916 10.1002/ssu.10021 (Pubitemid 37127474)
26. EL Lagow DD Carson 2002 Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-γ and tumor necrosis factor-α J Cell Biochem 86 759 772 12210742 10.1002/jcb.10261 1:CAS:528:DC%2BD38XmtVOhurs%3D (Pubitemid 34839977)
27. R Ahmad D Raina V Trivedi, et al. 2007 MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling Nat Cell Biol 9 1419 1427 18037881 10.1038/ncb1661 1:CAS:528:DC%2BD2sXhtlOns7bN (Pubitemid 350201755)
28. X Zhou MM DeSouza J Julian, et al. 1998 Estrogen receptor does not directly regulate the murine Muc-1 promoter Mol Cell Endocrinol 143 65 78 9806351 10.1016/S0303-7207(98)00141-5 1:CAS:528:DyaK1cXls1yjsb8%3D (Pubitemid 28458743)
29. MM Braz FS Ramalho RL Cardoso, et al. 2010 Slight activation of nuclear factor kappa-B is associated with increased hepatic stellate cell apoptosis in human schistosomal fibrosis Acta Trop 113 66 71 19781518 10.1016/j.actatropica. 2009.09.008 1:CAS:528:DC%2BD1MXhtlyjtr7O
30. H Nakshatri PB Nakshatri DA Martin, et al. 1997 Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth Mol Cell Biol 17 3629 3639 9199297 1:CAS:528:DyaK2sXktFOhtLY%3D (Pubitemid 27281838)
31. F Chang JT Lee PM Navolanic, et al. 2003 Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Leukemia 17 590 603 12646949 10.1038/sj.leu.2402824 1:CAS:528:DC%2BD3sXitFentb0%3D (Pubitemid 36395654)
32. JP Oliveira-Costa J Zanetti LR Oliveira, et al. 2010 Significance of topoisomerase IIIβ expression in breast ductal carcinomas: strong associations with disease-specific survival and metastasis Hum Pathol 41 1624 1630 20950730 10.1016/j.humpath.2010.01.027 1:CAS:528:DC%2BC3cXhtlSqurnM
33. A Urruticoechea IE Smith M Dowsett 2005 Proliferation marker Ki-67 in early breast cancer J Clin Oncol 23 7212 7220 16192605 10.1200/JCO.2005.07.501 1:CAS:528:DC%2BD2MXhtFCrsbfK
34. HS Ban M Uno H Nakamura 2010 Suppression of hypoxia-induced HIF-1a accumulation by VEGFR inhibitors: different profiles of AAL993 versus SU5416 and KRN633 Cancer Lett 296 17 26 20378243 10.1016/j.canlet.2010.03.010 1:CAS:528:DC%2BC3cXovFymsLc%3D
35. Q Qiao Y Nozaki K Sakoe, et al. 2010 NF-kB mediates aberrant activation of HIF-1 in malignant lymphoma Exp Hemathol 38 1199 1208 10.1016/j.exphem.2010. 08.007 1:CAS:528:DC%2BC3cXhsVGnsLrL
36. V Sharma D Dixit N Koul, et al. 2011 Ras regulates interleukin-1β- induced HIF-1α transcriptional activity in glioblastoma J Mol Med 89 123 136 20865400 10.1007/s00109-010-0683-5 1:CAS:528:DC%2BC3MXntVCqsA%3D%3D
37. IP Newton NS Kenneth PL Appleton, et al. 2010 Adenomatous polyposis coli and hypoxia-inducible factor-1α have an antagonistic connection Mol Biol Cell 21 3630 3638 20844082 10.1091/mbc.E10-04-0312 1:CAS:528:DC%2BC3cXhsFWhs7rL
38. M Raica AM Cimpeana D Ribatti 2009 Angiogenesis in pre-malignant conditions Eur J Cancer 45 1924 1934 19406633 10.1016/j.ejca.2009.04.007 1:CAS:528:DC%2BD1MXotFCjs7g%3D
39. BB Silva AR Santos CG Pires, et al. 2009 Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women Cell Prolif 42 506 510 19489979 10.1111/j.1365-2184.2009.00615.x
40. A Giatromanolaki MI Koukourakis E Sivridis, et al. 2000 Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways Clin Cancer Res 6 1917 1921 10815916 1:CAS:528:DC%2BD3cXktVWisLc%3D (Pubitemid 30305090)
41. JE Bluff SR Menakuru SS Cross, et al. 2009 Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease Br J Cancer 101 666 672 19623180 10.1038/sj.bjc.6605196 1:CAS:528:DC%2BD1MXpvFyisLg%3D